Allergan Funding SCS, an indirect subsidiary of Irish biopharmaceutical company Allergan, intends to raise funds through a registered public offering of euro-denominated senior unsecured notes with maturities of up to 12 years in multiple tranches.
The proceeds are intended to be used partly for purchasing the existing USD notes validly tendered and accepted for purchase, while the remaining will be used for general corporate purposes.
Go deeper with GlobalData
US-based biotechnology company BioCryst Pharmaceuticals intends to issue 11.7 million shares of its common stock to public.
The company has filed a registration statement with the US Securities and Exchange Commission (SEC) regarding the same.
French biotechnology company Oncodesign has reached an agreement to acquire certain businesses of Bertin Technologies’ subsidiary, Bertin Pharma.
See Also:
The acquisition includes service businesses in metabolism, pharmacokinetics, bio-analysis and translational medicine activities.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataChinese pharmaceutical company Hubei Jumpcan Pharmaceutical intends to raise up to ¥860m ($124.57m) by issuing convertible bonds to public.
Cytokinetics has announced the pricing for its proposed underwritten public offering of shares as $14.25 per share.
The issue will include 5.26 million shares to raise $75m in gross proceeds.
Underwriters to the offering will be granted a 30-day option to purchase up to an additional 789,000 shares.
The offering is expected to be completed on 12 May.
